Singh, Jatinder
Santosh, Paramala
Funding for this research was provided by:
Reverse Rett (Grant reference number: PCCTABR)
Article History
Received: 5 December 2017
Accepted: 10 July 2018
First Online: 31 July 2018
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: JS is on the professional advisory board for Reverse Rett. PS is the co-inventor of the HealthTrackerâ„¢ and is the Chief Executive Officer and shareholder in HealthTrackerâ„¢.JS is a Trial Research Methodologist and PS the Principal Investigator on the Sarizotan Clinical Trial (Protocol Number Sarizotan/001/II/2015; ExternalRef removed Identifier: NCT02790034) in patients with RTT.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.